Verified July 2026 · Cited to primary sources
Liraglutide: Evidence Grade A. FDA-approved / proven in humans.
The honest verdict
Grade A on the science, but in 2026 it is largely a legacy option: the daily injection and smaller weight effect make semaglutide or tirzepatide the usual first choice unless there is a specific reason to prefer it. If you and your prescriber land on liraglutide, we grade the molecule here and hand off the shopping. For provider comparison and where to get it, see glp1picks.com, our sister site.
Liraglutide at a glance
- Class
- GLP-1 receptor agonist
- Mechanism
- A once-daily GLP-1 analog with about 97 percent homology to native GLP-1 and a fatty-acid chain that extends its half-life to roughly 13 hours. It works through the same GLP-1 pathway as semaglutide (insulin secretion, slowed gastric emptying, central satiety) but requires daily dosing and produces more modest weight loss.
- Also known as
- Saxenda, Victoza, NN2211
- Research applications
- Chronic weight management
- Type 2 diabetes glycemic control
- Cardiovascular risk reduction in established disease
- Forms
- Subcutaneous injection (daily pen)
- Legal status
- FDA-approved
- WADA (anti-doping)
- Not on the WADA Prohibited List (2025). Not classified as performance-enhancing.
- Evidence grade
- Grade AFDA-approved / proven in humans
How we grade evidence
Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is Liraglutide?
The original daily GLP-1 for weight and diabetes: less powerful than the weekly agents that followed, but FDA-approved, decades-proven, and with a documented cardiovascular benefit.
A once-daily GLP-1 analog with about 97 percent homology to native GLP-1 and a fatty-acid chain that extends its half-life to roughly 13 hours. It works through the same GLP-1 pathway as semaglutide (insulin secretion, slowed gastric emptying, central satiety) but requires daily dosing and produces more modest weight loss.
How strong is the evidence for Liraglutide?
FDA-approved for chronic weight management (3.0 mg) and type 2 diabetes (up to 1.8 mg), with a large phase 3 evidence base. The SCALE Obesity and Prediabetes trial showed a mean 8.4 kg loss at 56 weeks versus 2.8 kg on placebo. The LEADER cardiovascular outcomes trial in 9,340 patients showed a 13 percent relative reduction in major cardiac events. Solid grade A, just outperformed on weight by the newer weekly agents.
Primary sources (2)
Is Liraglutide legal? (Status July 2026)
Prescription via a licensed provider.
What is Liraglutide used for?
Liraglutide is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.
What does Liraglutide cost, and how do you access it legally?
Typical cost
Varies widely by source and coverage
Pricing depends on brand, dose, and insurance. We do not quote provider prices here. For current provider pricing and access, see our sister site glp1picks.com.
How to access it legally
Liraglutideis FDA-approved, so the legal route is a prescription from a licensed provider, not a research vial. We don't currently have a vetted partner to link for it, so there's no button here. Ask a licensed clinician about the branded product. We never point you to gray-market or compounded off-label sources.
Trying to lose weight?
For weight loss, an approved GLP-1 beats this peptide.
No research peptide here has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site compares the options that actually work.
Is Liraglutidesafe? Side effects & risks
Well-characterized over more than a decade of use. Gastrointestinal effects (nausea, vomiting, diarrhea, constipation) are the most common and tend to settle with time. Carries a boxed warning for thyroid C-cell tumors (contraindicated with personal or family history of medullary thyroid carcinoma or MEN 2). Watch for pancreatitis and gallbladder disease. Daily injection is the main practical downside versus weekly agents. Not for use in pregnancy.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Liraglutide FAQ
Is liraglutide worse than semaglutide?
On weight loss, yes, it is more modest: about 8 percent average in SCALE versus roughly 15 percent for semaglutide, and it needs a daily injection instead of weekly. It is still FDA-approved and has its own proven cardiovascular benefit, so it remains a legitimate option, just not the most powerful one.
Where do I get liraglutide and what does it cost?
We keep provider pricing off this page on purpose. Our sister site handles that: for a live comparison of providers and current cost, see glp1picks.com.
Why would anyone choose daily liraglutide over a weekly option?
Reasons include tolerability (some people handle the daily titration better), specific prescriber preference, formulary or access constraints, or wanting a shorter-acting agent that clears faster if side effects appear. For most people starting today, a weekly agent is the default.
From our portfolio
Tracking Liraglutide?
Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.
Keep reading
MOTS-c
An "exercise-mimetic" metabolic peptide. Real mechanistic interest, but human evidence is association-only.
Grade ATesamorelin
One of only two FDA-approved peptides in this space. Proven to cut visceral fat, but approved for a narrow HIV indication.
Grade BRetatrutide
The next-generation weight-loss peptide with the strongest efficacy signal. But it is investigational and not yet available by any legal route.
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.